|
Screening for blood-borne
agents; problems and practicalities of screening large numbers
of patients; quality control of donor screening; medico-legal
implications (lessons from HIV and HCV, recipient screening and
follow-up etc.) screening for HIV, HBV and HCV, cost effectiveness;
positive donations; screening for other agents; future prospects.
Back
|
|